Tilray is proud to announce a collaboration with the Lower Mainland Chapter of the Multiple Sclerosis Society of Canada
on a public conversation about medical cannabis and other complementary therapies for the management of multiple sclerosis (MS) and the symptoms associated with this condition.
According to the MS Society, complementary therapies may include a wide variety of interventions including exercise, nutrition management programs and the use of medical cannabis. While MS is not currently curable, effective strategies including many of these complementary therapies can help modify or slow the disease course, treat relapses, manage symptoms, improve function and safety, and address emotional health.
“Tilray currently serves hundreds of patients with MS and we’re pleased to partner with the MS Society of Canada to provide education and information about medical cannabis in the treatment of MS for those who might consider adding this to their therapeutic options,” says Philippe Lucas, Vice-President of Patient Advocacy for Tilray.
The discussion is open to the public and, among others, will feature:
- Neurologist, Dr. David Parton, speaking about the use of medicinal cannabis;
- Natasha Wilch, BHk, MPT, CAFCI, PWR, exploring exercise and MS; and
- Cheryl Prince, RHN, LPN, focusing holistic nutrition
Participants will have the opportunity to learn from healthcare professionals, ask questions and increase their knowledge of complementary therapies for MS management.
The event will be held Saturday, March 5, 2016 from 1:00 to 4:00 pm PT at the Vancouver Island Conference Centre in Nanaimo, British Columbia. For more information about the event, please contact 250‐388‐6496 or email@example.com